CONTACT US

Side Effects/Safety:
chcsa-za-safety@cfao.com
Medical Queries:
zachc.medinfo@groupe-ethica.com
Product Quality Complaints:
chcsa-za-products@cfao.com

PRODUCT AND OPELLA DETAILS

S1 BUSCOPAN® 10 mg tablets. Each tablet contains hyoscine butylbromide 10 mg. Ref. No. E 501 (Act 101/1965)
S1 BUSCOPAN® 0,1 % syrup.Each 5 ml of syrup contains 5 mg of hyoscine butylbromide. Reg. No. Z/11.2/93

For full prescribing information refer to the Professional Information approved by the medicines regulatory authority.
Applicant: CFAO Healthcare South Africa (Pty) Ltd, Reg. no.: 2020/176440/07. 6th Floor, The Atium on 5th, Cnr Maude and 5th Street, Sandton, 2146. Tel: (011) 779 6500.